APhA Publishes Fourth Edition of Complete Math Review for the Pharmacy Technician

Published Online: Tuesday, July 1, 2014
PRESS RELEASE

WASHINGTON, DC, July 1, 2014 – The American Pharmacists Association (APhA) today released the fourth edition of Complete Math Review for the Pharmacy Technician. The textbook covers every topic related to pharmacy calculations that a pharmacy technician needs to know.

With more than 100 advance practice questions new to the fourth edition, the book contains 850 exercises spread throughout its 13 chapters, with answer key/solutions in the back. Filled with real-world practice problems and amusing illustrations, the book is a unique training resource, whether for the classroom, the national Pharmacy Technician Certification Examination, or the pharmacy practice setting.

Other features of this popular book are an Advanced Practice section at the end of each chapter, and a chapter titled “Medication Errors and Clinical Challenges,” which tests readers’ ability to recognize medication calculation errors sometimes made by nurses, pharmacists, and physicians. The book concludes with a 101-question post-test, each question being a real-world problem a technician might encounter in pharmacy practice.

William A. Hopkins, Jr, PharmD, is President of Clinical Pharmacy Consultants of North Georgia in Big Canoe, GA. Previously he was Professor of Pharmacy Administration and Pharmacy Practice at Mercer University College of Pharmacy in Atlanta. He is the author of the math chapters of the best-selling Pharmacy Technician Certification Quick-Study Guide.

The softbound textbook (ISBN 978-1-58212-197-0; 255 pages) may be purchased for $43.95 ($32 for APhA members) online, www.pharmacist.com/shop or by phone, 800-878-0729. It is one of seven books in the APhA Pharmacy Technician Training Series.
Latest Articles
Propranolol is red, digoxin is blue. Your pharmacist’s heart may skip a beat if they get a valentine from you.
Health-system pharmacists can play a critical role in managing drug shortages to prevent medical errors and adverse events.
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Vertex Pharmaceuticals has received a complete response letter from the FDA for its supplemental new drug application for ivacaftor.
Latest Issues
$auto_registration$